Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Am J Clin Oncol. 2016 Jun;39(3):248–254. doi: 10.1097/COC.0000000000000046

Table 4.

logistic-regression analysis of baseline serum proteins in the presence of ER/PR status.

Serum Protein Adjusted OR1 95% Confidence Interval P ER/PR status Adjusted OR2 95% Confidence Interval P
ANG-1 0.85 0.35–2.07 0.72 –/– 5.02 1.07–23.7 0.041
ANG-2 1.11 0.52–2.35 0.79 –/– 5.26 1.14–24.2 0.033
bFGF 1.22 0.73–2.04 0.46 –/– 4.62 0.97–22.1 0.055
IL-1a 3.05 0.99–9.43 0.053 –/– 9.32 1.53–56.9 0.016
MMP-9 1.07 0.26–4.44 0.93 –/– 5.24 1.10–25.0 0.038
PDGF-BB 1.16 0.48–2.79 0.74 –/– 5.64 1.17–27.1 0.031
PECAM-1 1.29 0.46–3.59 0.63 –/– 4.98 1.06–23.4 0.042
Tie-2 3.70 1.22–11.3 0.021 –/– 3.92 0.69–22.4 0.124
VEGF 1.72 0.92–3.23 0.091 –/– 7.61 1.36–42.6 0.021
VEGF-R2 1.56 0.56–4.35 0.40 –/– 5.05 1.08–23.6 0.040
1

Adjusted odds ratio favoring pCR with a one-unit increase in baseline level of the indicated serum protein, adjusting for the presence of ER/PR status in the logistic-regression model. Protein concentrations were normalized so that one unit of increase in baseline level is equal to the protein's interquartile range (IQR) at baseline.

2

Adjusted odds ratio favoring pCR in subjects with ER/PR=“–/–” compared to subjects with at least one “+”, adjusting for the presence of baseline serum-protein levels in the logistic-regression model.